These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 566675)

  • 1. [The pharmacology of 3,4-dihydroxyphenyl-alpha-hydroxypropionic acid sodium salt].
    Uspenskiĭ AE
    Farmakol Toksikol; 1978; 41(4):418-20. PubMed ID: 566675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacology of several aromatic amino acid decarboxylase inhibitors].
    Uspenskiĭ AE; Dabagov NS; Skoldinov AP
    Biull Eksp Biol Med; 1978 Oct; 86(10):444-7. PubMed ID: 309344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl 1-alanine and its analogs.
    DeFeudis FV
    Rev Clin Basic Pharm; 1988; 7(1-4):207-8. PubMed ID: 3247497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
    Goshima Y; Nakamura S; Misu Y
    J Pharmacol Exp Ther; 1991 Aug; 258(2):466-71. PubMed ID: 1865350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of L-DOPA on aggressive behavior and central monoaminergic activity in the lizard Anolis carolinensis, using a new method for drug delivery.
    Höglund E; Korzan WJ; Watt MJ; Forster GL; Summers TR; Johannessen HF; Renner KJ; Summers CH
    Behav Brain Res; 2005 Jan; 156(1):53-64. PubMed ID: 15474650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of 1-DOPA on emotional responses and serotonin metabolism in the rat brain].
    Allikmets LKh; Zharkovskiĭ AM
    Biull Eksp Biol Med; 1976 Feb; 81(2):134-7. PubMed ID: 1084170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The central action of lithium chloride.
    Wielosz M
    Pol J Pharmacol Pharm; 1974; 26(4):399-409. PubMed ID: 4472349
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase.
    Borri Voltattorni C; Bertoldi M; Bianconi S; Deng WP; Wong K; Kim I; Herbert B; Kirk KL
    Biochem Biophys Res Commun; 2002 Jul; 295(1):107-11. PubMed ID: 12083775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
    Matsushita N; Misu Y; Goshima Y
    Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Facilitation of the effects of L-DOPA by alpha-methyldopa].
    Uspenskiĭ AE; Korobov NV
    Biull Eksp Biol Med; 1976 Mar; 81(3):314-6. PubMed ID: 986203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of compound WA-335 on the central nervous system.
    Maj J; Baran L; Sowińska H; Gancarczyk L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-DOPA cyclohexyl ester is a novel stable and potent competitive antagonist against L-DOPA, as compared to L-DOPA methyl ester.
    Misu Y; Goshima Y; Miyamae T; Furukawa N; Sugiyama Y; Okumura Y; Shimizu M; Ohshima E; Suzuki F
    Jpn J Pharmacol; 1997 Nov; 75(3):307-9. PubMed ID: 9434265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase.
    Wilke WL
    Pediatr Res; 1983 Nov; 17(11):924-5. PubMed ID: 6359046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
    Shimamura M; Shimizu M; Yagami T; Funabashi T; Kimura F; Kuroiwa Y; Misu Y; Goshima Y
    Neuropharmacology; 2006 Jun; 50(8):909-16. PubMed ID: 16504219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural and neurochemical response of alpha-synuclein A30P transgenic mice to the effects of L-DOPA.
    Oksman M; Tanila H; Yavich L
    Neuropharmacology; 2009 Mar; 56(3):647-52. PubMed ID: 19084027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ; Porter CC
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review on the relationship between nicotinic acetylcholine receptors and dopaminergic neurotransmission in the central nervous system--dopa is an endogenous neuroactive substance.
    Misu Y; Nakamura S; Goshima Y; Yue JL; Miyamae T; Kubo T
    Yakubutsu Seishin Kodo; 1993 Jun; 13(3):199-210. PubMed ID: 8237136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.